| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Invivyd, Inc. (IVVD) has 12 insiders with recent SEC Form 4 filings, including 13 buys and 5 sells. IVVD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 820.0K | $1.17M | - | |
| Other | 675.0K | $965.3K | - | |
| Other | 675.0K | $965.3K | - | |
| Other | 625.0K | $893.8K | - | |
| CFO | 625.0K | $893.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | McGuire Terrance | Director | Sell | 485,400 | $0.60 | $289,377.44 | -3.6% | +44.8% | +307.5% | |
| May 29, 2024 | McGuire Terrance | Director | Sell | 112,381 | $1.66 | $186,574.94 | -2.3% | -45.2% | -49.5% | |
| Jan 19, 2024 | Adimab, LLC | 10% Owner | Sell | 5,000,000 | $3.95 | $19,750,000.00 | -18.7% | -50.0% | -91.4% | |
| Sep 1, 2022 | Hering David | Chief Executive Officer | Buy | 8,000 | $4.52 | $36,160.00 | New | -51.2% | -60.5% | |
| Aug 19, 2022 | Elia Marc | Director, See Footnote 5 | Buy | 2,850,000 | $4.28 | $12,194,679.81 | +12.7% | -20.5% | -62.6% | |
| Aug 10, 2021 | Mithril II LP | 10% Owner | Buy | 1,997,000 | $17.00 | $33,949,000.00 | +21.6% | -20.6% | -83.6% | |
| Aug 10, 2021 | McGuire Terrance | Director | Buy | 500,000 | $17.00 | $8,500,000.00 | +6.2% | -20.6% | -83.6% | |
| Aug 10, 2021 | Royan Ajay | Director, 10% Owner | Buy | 1,997,000 | $17.00 | $33,949,000.00 | +21.6% | -20.6% | -83.6% | |
| Aug 10, 2021 | Redmile Group, LLC47 | 10% Owner | Buy | 1,470,000 | $17.00 | $24,990,000.00 | +76.5% | -20.6% | -83.6% |